Table 1.
Clinical characteristics and baseline demographics of the 80 sepsis patientsa.
Characteristics | ||
---|---|---|
Demographics | ||
Female/male (n, %) | 36/44 | (45/55%) |
Age (years, range) | 74.5 | (38-87) |
Age >65/<65 | 58/22 | (72.5/27.5%) |
Clinical parameters | ||
APACHE II score | 26.2 | (3-38.9) |
SOFA score | 4 | (2-13) |
Laboratory data | ||
PaO2/FiO2 | 140 | (45-920) |
Lactate (mmol/L) | 2.1 | (0.3-14.4) |
White blood cells (×109/L) | 12.8 | (0.42-51.55) |
Platelet (×109/L) | 196 | (9-445) |
Hemoglobin (g/dL) | 11.4 | (4.3-17.3) |
Hematocrit (%) | 33.8 | (12.5-49.2) |
Prothrombin time in INR, ratio | 1.18 | (0.93-3.62) |
Total bilirubin (mg/dL) | 0.8 | (0.3-3.8) |
AST (U/dL) | 27 | (8-1470) |
ALT (U/dL) | 19 | (5-2100) |
Lactate dehydrogenase (IU/dL) | 521 | (138-2492) |
BUN (mg/dL) | 24.05 | (8.2-184.1) |
Creatinine (mg/dL) | 1.06 | (0.3-23.8) |
Final diagnosis | ||
Urinary tract infection (n, %) | 32 | (40%) |
Respiratory tract infection (n, %) | 36 | (45%) |
Digestive tract infection (n, %) | 4 | (5%) |
Hepatobiliary tract infection (n, %) | 3 | (3.7%) |
Others (n, %) | 5 | (6.3%) |
Underlying disease | ||
HTN/DM (n, %) | 10/6 | (12.5/7.5%) |
HTN + DM (n, %) | 13 | (16.3%) |
Prognosis | ||
Survivor (n, %) | 63 | (78.7%) |
Nonsurvivor (n, %) | 17 | (21.2%) |
aData are presented as median (range) for continuous variables and frequency (%) for categorical variables. APACHE: acute physiology and chronic health evaluation; SOFA: sequential organ failure assessment; AST: aspartate aminotransferase; ALT: alanine aminotransferase; HTN: hypertension; DM: diabetes mellitus.